According to its early response to LL-37 activation, we proofed that an addition of IL17A amplified the activating effects of LL-37 on the co-expression of HAS genes, together with the expression of proinflammatory cytokines involved in RA pathogenesis. The gene discussed is HAS1; the disease is rheumatoid arthritis.